Wednesday, December 25, 2024
- Advertisement -spot_img

TAG

Sentynl Therapeutics Inc

Zydus acquires rights for progeria treatment – Times of India

Ahmedabad: Sentynl Therapeutics Inc (Sentynl), a US-based biopharmaceutical company which is also wholly owned by Ahmedabad-headquartered Zydus Lifesciences, recently closed its acquisition of global...

Latest news

- Advertisement -spot_img